Case study: conversion of a liver transplant patient from cyclosporine Sandimmune to Neoral.
Levy
G A
GA
Multi Organ Transplant Program, Toronto Hospital, University of Toronto, Canada.
D000284:Administration, Oral; D000410:Alanine Transaminase / Q000097:blood; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001219:Aspartate Aminotransferases / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use*; D004304:Dosage Forms; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology*; D008776:Methylprednisolone Hemisuccinate / Q000627:therapeutic use; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use
D000961:Antilymphocyte Serum; D004304:Dosage Forms; D007166:Immunosuppressive Agents; D008776:Methylprednisolone Hemisuccinate; D016572:Cyclosporine; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D011241:Prednisone